Apeloa Pharmaceutical Co.,Ltd (SHE:000739)
China flag China · Delayed Price · Currency is CNY
18.22
+0.38 (2.13%)
Feb 3, 2026, 1:05 PM CST

SHE:000739 Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Sep '25 Dec '24 Dec '23 Jan '23 Jan '22 Dec '20
Cash & Equivalents
3,5323,6623,5813,5532,6102,194
Trading Asset Securities
0.02--0.0914.89116.22
Cash & Short-Term Investments
3,5323,6623,5813,5532,6252,310
Cash Growth
-9.28%2.26%0.78%35.35%13.61%54.06%
Accounts Receivable
2,1522,2652,2432,0401,5231,256
Other Receivables
6.66112.26114.46116.28103.7461.54
Receivables
2,1592,4332,4212,1561,6261,318
Inventory
1,6021,8602,0831,8021,2501,086
Prepaid Expenses
-4.6426.6520.5913.0616.04
Other Current Assets
292.96227.8256.96249.5267.72187.1
Total Current Assets
7,5858,1878,3687,7815,7824,917
Property, Plant & Equipment
3,6293,7753,5643,4062,5881,981
Long-Term Investments
200.51139.66174.0591.4181.25121.74
Goodwill
20.3120.3120.3120.3120.3120.31
Other Intangible Assets
302.83314.61319.8338.93346.05339.9
Long-Term Deferred Tax Assets
232.26227.66247.4270.2947.5839.57
Long-Term Deferred Charges
61.8715.7720.5766.2146.7611.96
Other Long-Term Assets
69.7349.3253.7547.15133.2262.69
Total Assets
12,10212,72912,76812,0219,0457,495
Accounts Payable
3,3333,6334,1274,3112,6231,929
Accrued Expenses
220.25251.62226.43202.82221.62249.4
Short-Term Debt
1,038814.03807.8562.81332.47330.28
Current Portion of Long-Term Debt
-581.340.40.2-
Current Portion of Leases
-6.617.988.6513.77-
Current Income Taxes Payable
153.7292.3377.0480.59120.56131.04
Current Unearned Revenue
105.01514.33430.37458.26302.4136.19
Other Current Liabilities
467.52425.26550.05402.44165.8120.88
Total Current Liabilities
5,3175,7436,3086,0273,7792,896
Long-Term Debt
173.170.0518.71249.62104.94-
Long-Term Leases
13.4813.784.4715.8122.95-
Long-Term Unearned Revenue
31.831.6930.6215.121.17125.43
Long-Term Deferred Tax Liabilities
72.5484.98103.71122.964.2510.22
Other Long-Term Liabilities
-3672727272
Total Liabilities
5,6085,9796,5376,5023,9853,104
Common Stock
1,1581,1691,1791,1791,1791,179
Additional Paid-In Capital
104.79247438.01438.01438.01438.01
Retained Earnings
5,3685,4814,8044,0963,4432,774
Treasury Stock
-143.6-153.09-200.2-200.2--
Comprehensive Income & Other
-1.08-2.022.01-0.790.430.27
Total Common Equity
6,4866,7426,2235,5125,0604,391
Minority Interest
7.847.927.697.35--
Shareholders' Equity
6,4946,7506,2305,5195,0604,391
Total Liabilities & Equity
12,10212,72912,76812,0219,0457,495
Total Debt
1,224909.47920.3837.3474.33330.28
Net Cash (Debt)
2,3082,7522,6602,7162,1511,980
Net Cash Growth
-21.38%3.45%-2.04%26.27%8.61%36.59%
Net Cash Per Share
2.002.372.282.311.821.68
Filing Date Shares Outstanding
1,1481,1581,1691,1691,1791,179
Total Common Shares Outstanding
1,1481,1581,1691,1691,1791,179
Working Capital
2,2682,4442,0601,7552,0032,021
Book Value Per Share
5.655.825.324.714.293.73
Tangible Book Value
6,1636,4075,8835,1534,6944,030
Tangible Book Value Per Share
5.375.535.034.413.983.42
Buildings
-1,9911,7431,7431,4741,456
Machinery
-4,7674,3984,1262,9032,755
Construction In Progress
-407.48545.85311.4710.22158.7
Source: S&P Global Market Intelligence. Standard template. Financial Sources.